Meeting
2018 ASCO Annual Meeting
A 12 multigene NGS panel to characterize molecular biotypes in endometrial cancer.
Authors
Ignacio Romero
Instituto Valenciano de Oncología (IVO), Valencia, Spain
Ignacio Romero , Raquel López Reig , Antonio Fernandez-Serra , Zaida Garcia-Casado , Cristina Zorrero , Carmen Illueca , Andres Poveda , Jose Antonio Lopez-Guerrero
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 36, 2018 (suppl; abstr 5591)
DOI
10.1200/JCO.2018.36.15_suppl.5591
Abstract #
5591
Poster Bd #
318
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Genetic variations in endometrial cancer by histology, stage and BMI.
First Author: Dario R. Roque
Poster
2016 ASCO Annual Meeting
Use of next-generation sequencing (NGS) panels to predict recurrence in low-grade, early-stage endometrioid endometrial carcinoma.
First Author: Katherine Kurnit
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Plasma-informed minimal residual disease (MRD) assay: A multicenter prospective study in Japanese patients with stage II colorectal cancer.
First Author: Eiji Oki
Poster
2020 Gastrointestinal Cancers Symposium
Clinical utility of targeted next generation sequencing (NGS) to predict response to neoadjuvant therapy (NT) in rectal cancer (RC).
First Author: Kristen Carroll